Innovative Medicines Canada is appointing Patrick Hupé as vice-president of government and stakeholder relations.
He brings more than 25 years of experience in medical technology and life sciences, including senior roles at Medtronic, Pfizer Inc. and Hoffmann-La Roche Ltd. According to a press release, Hupé has led high-performing, multi-disciplinary teams and executed large-scale initiatives to improve access to innovative technologies, partnering with government officials, policymakers, regulatory bodies and public health leaders.
Read: Innovative Medicines Canada calling on feds to clarify impact of pharmacare on private drug plans
“As we navigate a rapidly evolving health-care landscape, Patrick’s insights and expertise will be instrumental in advancing policies that enhance patient care and expand access to life-changing treatments,” said Dr. Bettina Hamelin, president of Innovative Medicines Canada, in the release. “His experience working with government leaders and stakeholders will ensure IMC remains a trusted partner in shaping policies that benefit all Canadians.”
Read more People Watch news.